Abstract
The rapid evolution of immunopharmacology as a recognized scientific discipline dedicated to unraveling complex interrelationships between immunologic responsiveness and disease states in general supports the importance of the potential role biological response modifiers have in clinical medicine. To administer a drug, or combination of drugs, that safely, effectively, and favorably alter the course of infection, cancer, autoimmune disease, and allergy is within grasp. Although the greatest emphasis on therapeutic application of BRMs is placed on cancer, many of these immunomodulating agents have well-documented effects on the course of infectious disease. By either restoring immune responses or by enhancing the response of a normal immune system, it is conceivable that BRM therapy will someday be used routinely as adjunct therapy in the management of viral infections in companion animals.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Veterinary Clinics of North America: Small Animal Practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
